Literature DB >> 2447018

Antigenic and structural characterization of Treponema pallidum (Nichols strain) endoflagella.

D R Blanco1, C I Champion, J N Miller, M A Lovett.   

Abstract

Purified endoflagella from Treponema pallidum, Nichols strain, were characterized both structurally and antigenically. Structural analysis showed T. pallidum endoflagella are composed of 35- and 33-kilodalton (kDa) subunits which lack cysteine and do not share N-terminal amino acid sequence homology (20 residues). Intact endoflagella were dissociated into the composite subunits by incubation, which disrupts noncovalent bonds. Antiserum raised against purified T. pallidum endoflagella identified shared epitopes on the endoflagellar polypeptides of the nonpathogen, Treponema phagedenis biotype Reiter. Pathogen-specific epitopes were also found on the 35- and 33-kDa polypeptides by using affinity-purified endoflagellar antibodies. The pathogen-specific epitopes were localized by immunoblotting analysis of chymotryptic digests of the endoflagellar subunits; 18- and 26-kDa fragments derived from the 35-kDa subunit were found to possess a majority of the pathogen-specific epitopes. Both the 35- and 33-kDa subunits had surface exposure, as determined by immunoelectron microscopy, although additional immunochemical data indicated that the surface exposure of the 35-kDa subunit was greater.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447018      PMCID: PMC259252          DOI: 10.1128/iai.56.1.168-175.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Flagellar structure and function in eubacteria.

Authors:  R N Doetsch; R D Sjoblad
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

2.  Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins.

Authors:  M Morrison
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen.

Authors:  T E Fehniger; A M Walfield; T M Cunningham; J D Radolf; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Humoral immune response in human syphilis to polypeptides of Treponema pallidum.

Authors:  P A Hanff; T E Fehniger; J N Miller; M A Lovett
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  Purification of Treponema pallidum, Nichols strain, by Percoll density gradient centrifugation.

Authors:  P A Hanff; S J Norris; M A Lovett; J N Miller
Journal:  Sex Transm Dis       Date:  1984 Oct-Dec       Impact factor: 2.830

6.  Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis.

Authors:  M Moskophidis; F Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.

Authors:  S A Lukehart; S A Baker-Zander; E R Gubish
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

8.  The axial filament antigen of Treponema pallidum.

Authors:  C W Penn; M J Bailey; A Cockayne
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

9.  Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans.

Authors:  S A Baker-Zander; E W Hook; P Bonin; H H Handsfield; S A Lukehart
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

10.  Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum.

Authors:  P A Hanff; N H Bishop; J N Miller; M A Lovett
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

View more
  30 in total

Review 1.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  N-terminal amino acid sequences and amino acid compositions of the Spirochaeta aurantia flagellar filament polypeptides.

Authors:  J Parales; E P Greenberg
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

3.  Expression in Escherichia coli of the 37-kilodalton endoflagellar sheath protein of Treponema pallidum by use of the polymerase chain reaction and a T7 expression system.

Authors:  R D Isaacs; J D Radolf
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Kinetics of pathogen-specific humoral response in Treponema pallidum-infected young and old inbred strain 2 guinea pigs.

Authors:  V Wicher; J Zabek; K Wicher
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  FlaA, a putative flagellar outer sheath protein, is not an immunodominant antigen associated with Lyme disease.

Authors:  Y Ge; N W Charon
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Isolation and characterization of the outer membrane of Borrelia hermsii.

Authors:  E S Shang; J T Skare; M M Exner; D R Blanco; B L Kagan; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

7.  Structure and expression of the FlaA periplasmic flagellar protein of Borrelia burgdorferi.

Authors:  Y Ge; C Li; L Corum; C A Slaughter; N W Charon
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

8.  Identification and characterization of an endoflagellar antigen of Borrelia burgdorferi.

Authors:  J L Coleman; J L Benach
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

9.  Isolation of extracytoplasmic proteins from Serpulina hyodysenteriae B204 and molecular cloning of the flaB1 gene encoding a 38-kilodalton flagellar protein.

Authors:  J D Gabe; R J Chang; R Slomiany; W H Andrews; M T McCaman
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Characterization of Borrelia burgdorferi proteins reactive with antibodies in synovial fluid of a patient with Lyme arthritis.

Authors:  N Mensi; D R Webb; C W Turck; G A Peltz
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.